Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Friedman

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Journal of Virology|August 1, 1996
Disulfide bond structure determination and biochemical analysis of glycoprotein C from herpes simplex virusA H Rux, W T Moore, J D Lambris, et al.
Molecular and Cellular Biology|June 1, 1989
Use of a glucocorticoid-inducible promoter for expression of herpes simplex virus type 1 glycoprotein gC1, a cytotoxic protein in mammalian cellsH M Friedman, A Yee, H Diggelmann, et al.
Annals of Internal Medicine|April 1, 1991
Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trialS A Plotkin, S E Starr, H M Friedman, et al.
Annals of Internal Medicine|November 1, 1979
Live cytomegalovirus vaccination of renal transplant candidates. A preliminary trialJ P Glazer, H M Friedman, R A Grossman, et al.
Transplantation|August 1, 1985
The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantationM L Smiley, C G Wlodaver, R A Grossman, et al.
Journal of Virology|September 12, 1998
Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivoJ M Lubinski, L Wang, A M Soulika, et al.
Lancet (London, England)|March 10, 1984
Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplantsS A Plotkin, M L Smiley, H M Friedman, et al.
The New England Journal of Medicine|April 18, 1996
Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials GroupA C Collier, R W Coombs, D A Schoenfeld, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Journal of Virology|August 1, 1996
Disulfide bond structure determination and biochemical analysis of glycoprotein C from herpes simplex virusA H Rux, W T Moore, J D Lambris, et al.
Molecular and Cellular Biology|June 1, 1989
Use of a glucocorticoid-inducible promoter for expression of herpes simplex virus type 1 glycoprotein gC1, a cytotoxic protein in mammalian cellsH M Friedman, A Yee, H Diggelmann, et al.
Annals of Internal Medicine|April 1, 1991
Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trialS A Plotkin, S E Starr, H M Friedman, et al.
Annals of Internal Medicine|November 1, 1979
Live cytomegalovirus vaccination of renal transplant candidates. A preliminary trialJ P Glazer, H M Friedman, R A Grossman, et al.
Transplantation|August 1, 1985
The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantationM L Smiley, C G Wlodaver, R A Grossman, et al.
Journal of Virology|September 12, 1998
Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivoJ M Lubinski, L Wang, A M Soulika, et al.
Lancet (London, England)|March 10, 1984
Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplantsS A Plotkin, M L Smiley, H M Friedman, et al.
The New England Journal of Medicine|April 18, 1996
Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials GroupA C Collier, R W Coombs, D A Schoenfeld, et al.
Pageof 10